Unusual Prenatal Genomic Results Provide Proof-of-Principle of the Liquid Biopsy for Cancer Screening-Reference-Cited by-同舟云学术

Unusual Prenatal Genomic Results Provide Proof-of-Principle of the Liquid Biopsy for Cancer Screening

Published:2018-02-01 Issue:2 Volume:64 Page:254-256
ISSN:0009-9147
Container-title:Clinical Chemistry
language:en
Short-container-title:

Author:

Bianchi Diana W¹

Affiliation:

1. Prenatal genomics and Therapy Section, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD

Publisher

Oxford University Press (OUP)

Subject

Biochemistry, medical,Clinical Biochemistry

Link

http://academic.oup.com/clinchem/article-pdf/64/2/254/32641371/clinchem0254.pdf

Reference15 articles.

1. What to expect when you're expecting;Murkoff,2016

2. Incidental detection of maternal neoplasia in noninvasive prenatal testing;Dharajiya;Clin Chem,2018

3. Prenatal and pre-implantation genetic diagnosis;Vermeesch;Nat Rev Genet,2016

4. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?;Mennuti;Am J Obstet Gynecol,2013

5. Non-invasive, serum DNA pregnancy testing leading to incidental discovery of cancer: a good thing?;Prasad;Eur J Cancer,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Recommendations for the Clinical Management of Pregnant Women With Noninvasive Prenatal Test Results Suspicious of a Maternal Malignancy;JCO Oncology Practice;2024-08

2. Maternal Malignancy After Atypical Findings on Single-Nucleotide Polymorphism–Based Prenatal Cell-Free DNA Screening;Obstetrics & Gynecology;2023-03-09

3. Prenatal DNA Sequencing for Fetal Aneuploidy Also Detects Maternal Cancer: Importance of Timely Workup and Management in Pregnant Women;Journal of Clinical Oncology;2022-08-01

4. Liquid biopsy: state of reproductive medicine and beyond;Human Reproduction;2021-09-25

5. Cancer Diagnoses Following Abnormal Noninvasive Prenatal Testing: A Case Series, Literature Review, and Proposed Management Model;JCO Precision Oncology;2021-05